BioSpace News Archive

Drug Development

Cellectis CEO Provides Update on UCART Programs and ‘Laser Focus’ of Company in 2018

After a brief stumble with UCART123 that resulted in a clinical hold last year, Cellectis is moving on with its study.

January 23, 2018
·
3 min read
·
Alex Keown
Deals

Top 3 Takeover Targets for Pfizer

The year is already off to a good start with mergers and acquisitions in the biopharma industry.

January 23, 2018
·
3 min read
·
Mark Terry
Business

Biotech Startup Formed by 4 Ex-Pfizer Employees Inks Deal With Former Employer

The companies will collaborate on research to study a previously unrecognized role for peripheral immune cells in the pathology of central nervous system disorders.

January 23, 2018
·
2 min read
·
Alex Keown
China Sees Promise, not Danger in Crispr Gene-Editing Trials

China researchers have treated 86 cancer patients with genetically modified versions of their own immune cells.

January 23, 2018
·
1 min read
Business

AI Biotech Startup XtalPi Scores $15M From Google, Tencent and Sequoia

The latest funding round gives XtalPi $20M in the bank, which the company said makes it “one of the top-funded AI-powered biotechs.”

January 23, 2018
·
2 min read
·
Alex Keown
Pharm Country

New Kid Tmunity Banks $100M From Gilead and Facebook Billionaire Sean Parker

The funds raised will partly go towards funding two clinical trials that have already opened.

January 23, 2018
·
3 min read
·
Mark Terry
Drug Development

Zealand Pharma to Present Phase II Results on Glepaglutide at the ASPEN 2018 Conference in Las Vegas, U.S.

The trial was conducted at Rigshospitalet, University of Copenhagen, Denmark, one of the world’s leading centers for the treatment of SBS and top-line results were reported in June 2017

January 23, 2018
·
3 min read
FDA

FDA OKs Topcon’s Ocular Diagnostic Instrument

Topcon’s touted its system as being able to quickly penetrate ocular tissues without being obscured by hemorrhage or media opacities.

January 23, 2018
·
1 min read
Deals

Gilead’s Kite Pays $135M for Ex-Agensys R&D Building

The latest acquisition makes it the highest amount paid for a flex R&D building in Los Angeles County.

January 23, 2018
·
1 min read
Deals

How Juno’s CEO Broke the $9B M&A News to Employees

Employees of Juno received a surprise in their Monday morning emails.

January 23, 2018
·
2 min read
·
Alex Keown